MWNA
UTHR icon

Marshall Wace North America’s United Therapeutics UTHR Stock Holding History

Marshall Wace North America’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$20.7M Buy
+112,359
New +$22.1M 0.09% 231
2021
Q2 		– Sell
-272,286
Closed -$45.5M – 1794
2021
Q1 		$45.5M Sell
272,286
-38,023
-12% -$6.34M 0.19% 127
2020
Q4 		$47.1M Sell
310,309
-70,737
-19% -$9.28M 0.21% 123
2020
Q3 		$38.5M Buy
381,046
+62,710
+20% +$6.88M 0.25% 102
2020
Q2 		$38.5M Buy
318,336
+287,192
+922% +$32.3M 0.25% 103
2020
Q1 		$2.95M Buy
+31,144
New +$2.96M 0.02% 412
2019
Q3 		– Sell
-7,772
Closed -$606K – 1567
2019
Q2 		$606K Buy
+7,772
New +$727K ﹤0.01% 854
2019
Q1 		– Sell
-12,327
Closed -$1.34M – 1917
2018
Q4 		$1.34M Buy
+12,327
New +$1.43M 0.01% 541
2018
Q3 		– Sell
-3,154
Closed -$357K – 1384
2018
Q2 		$357K Buy
+3,154
New +$347K ﹤0.01% 1147
2017
Q4 		– Sell
-31,964
Closed -$3.74M – 1627
2017
Q3 		$3.74M Buy
+31,964
New +$4.08M 0.02% 630
2017
Q2 		– Sell
-70,630
Closed -$9.54M – 1474
2017
Q1 		$9.54M Buy
+70,630
New +$10.7M 0.08% 282
2013
Q4 		$214K Buy
+1,891
New +$171K ﹤0.01% 634

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace North America's UTHR Position: Q3 2021 in Review

Marshall Wace North America opened a new position in United Therapeutics (UTHR) in Q3 2021: 112,359 shares worth $20.7M. The stake represents 0.09% of the portfolio and ranks #231 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in UTHR as recently as Q1 2021.

Marshall Wace North America first reported a position in UTHR in Q4 2013 and has held it in 12 quarters since. The position peaked at $47.1M in Q4 2020. 426 funds tracked by Wall St. Rank hold UTHR as of Q3 2021.

  • Marshall Wace North America held 112,359 shares of United Therapeutics worth $20.7M as of Q3 2021.
  • United Therapeutics was a new Marshall Wace North America position in Q3 2021.
  • United Therapeutics made up 0.09% of Marshall Wace North America's portfolio in Q3 2021, its #231 holding.
  • Marshall Wace North America first reported a position in United Therapeutics in Q4 2013 and has held it in 12 quarters since.
  • Marshall Wace North America's United Therapeutics position peaked at $47.1M in Q4 2020.
  • 426 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.